Genetics of Inflammatory Bowel Disease. A Personal View on Progress and Prospects
- 1 January 1998
- journal article
- review article
- Published by S. Karger AG in Digestive Diseases
- Vol. 16 (6), 370-374
- https://doi.org/10.1159/000016894
Abstract
Clinical, epidemiological and molecular data reported in the last 5 years have provided strong evidence that genetic factors are important in susceptibility to both Crohn’s disease and ulcerative colitis. The model of disease inheritance which best fits the epidemiological data is that Crohn’s disease and ulcerative colitis are related polygenic diseases. However, genetic heterogeneity is likely to be extensive, and may well underlie the variability in clinical presentation associated with inflammatory bowel disease. Considerable progress has already been made in identifying potential disease susceptibility loci using the technique of genome-wide scanning. There is optimism that international collaborative studies will allow fine mapping of the loci implicated on chromosomes 16 and 12. The identification of novel susceptibility genes has become a realistic goal for investigators. Once this has been achieved, there are likely to be immediate clinical benefits, both in understanding disease pathophysiology, and in disease management.Keywords
This publication has 4 references indexed in Scilit:
- Linkage and Association between Inflammatory Bowel Disease and a Locus on Chromosome 12American Journal of Human Genetics, 1998
- Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1Proceedings of the National Academy of Sciences, 1998
- Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosisThe Lancet, 1996
- Mapping of a susceptibility locus for Crohn's disease on chromosome 16Nature, 1996